DK1027889T3 - Middel til transdermal applikation indeholdende ergolinderivater - Google Patents

Middel til transdermal applikation indeholdende ergolinderivater

Info

Publication number
DK1027889T3
DK1027889T3 DK00250117T DK00250117T DK1027889T3 DK 1027889 T3 DK1027889 T3 DK 1027889T3 DK 00250117 T DK00250117 T DK 00250117T DK 00250117 T DK00250117 T DK 00250117T DK 1027889 T3 DK1027889 T3 DK 1027889T3
Authority
DK
Denmark
Prior art keywords
transdermal application
application containing
ergoline derivatives
opt
ergoline
Prior art date
Application number
DK00250117T
Other languages
English (en)
Inventor
Jutta Dr Riedl
Clemens Dr Guenther
Ralph Dr Lipp
Original Assignee
Neurobiotec Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Neurobiotec Gmbh filed Critical Neurobiotec Gmbh
Application granted granted Critical
Publication of DK1027889T3 publication Critical patent/DK1027889T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7053—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained by reactions only involving carbon to carbon unsaturated bonds, e.g. polyvinyl, polyisobutylene, polystyrene
    • A61K9/7061—Polyacrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/48—Ergoline derivatives, e.g. lysergic acid, ergotamine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
    • A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
    • A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
DK00250117T 1991-05-18 1992-05-14 Middel til transdermal applikation indeholdende ergolinderivater DK1027889T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE4116912A DE4116912A1 (de) 1991-05-18 1991-05-18 Mittel zur transdermalen applikation enthaltend ergolin-derivate
EP92909703A EP0538433B1 (de) 1991-05-18 1992-05-14 Mittel zur transdermalen applikation enthaltend ergolin-derivate

Publications (1)

Publication Number Publication Date
DK1027889T3 true DK1027889T3 (da) 2006-04-18

Family

ID=6432298

Family Applications (1)

Application Number Title Priority Date Filing Date
DK00250117T DK1027889T3 (da) 1991-05-18 1992-05-14 Middel til transdermal applikation indeholdende ergolinderivater

Country Status (14)

Country Link
US (1) US5399355A (da)
EP (2) EP1027889B8 (da)
JP (1) JP3725153B2 (da)
AT (2) ATE264679T1 (da)
AU (1) AU1637792A (da)
CA (1) CA2068970C (da)
DE (3) DE4116912A1 (da)
DK (1) DK1027889T3 (da)
ES (2) ES2251936T3 (da)
HU (1) HUT64227A (da)
IE (1) IE921586A1 (da)
NO (1) NO930148D0 (da)
PT (1) PT100492B (da)
WO (1) WO1992020339A1 (da)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0695177T3 (da) * 1993-04-20 1998-09-28 Hexal Ag Plaster indeholdende aktivt stof
DE19626621A1 (de) * 1996-07-02 1998-01-08 Hexal Ag Pflaster zur transdermalen Anwendung von Pergolid
US5837289A (en) * 1996-07-23 1998-11-17 Grasela; John C. Transdermal delivery of medications using a combination of penetration enhancers
US5900249A (en) * 1998-02-09 1999-05-04 Smith; David J. Multicomponent pain relief topical medication
FR2793890B1 (fr) 1999-05-19 2002-01-18 France Telecom Boitier d'acces a une ou plusieurs fibres optiques dans un cable tendu
DE10033853A1 (de) * 2000-07-12 2002-01-31 Hexal Ag Transdermales therapeutisches System mit hochdispersem Siliziumdioxid
DE10043321B4 (de) * 2000-08-24 2005-07-28 Neurobiotec Gmbh Verwendung eines transdermalen therapeutischen Systems zur Behandlung der Parkinsonschen Krankheit, zur Behandlung und Prävention des prämenstruellen Syndroms und zur Lactationshemmung
US20070243240A9 (en) * 2000-08-24 2007-10-18 Fred Windt-Hanke Transdermal therapeutic system
DE10053397A1 (de) * 2000-10-20 2002-05-02 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
DE10064453A1 (de) * 2000-12-16 2002-07-04 Schering Ag Verwendung eines dopaminergen Wirkstoffes zur Behandlung von dopaminerg behandelbaren Erkrankungen
CA2447444A1 (en) * 2001-05-11 2002-11-21 Orasense, Ltd. Antisense permeation enhancers
DE10137082A1 (de) * 2001-07-28 2003-02-13 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
DE10137162A1 (de) * 2001-07-30 2003-02-20 Hexal Ag Matrixkontrolliertes transdermales therapeutisches System zur Anwendung von Pramiprexol und Ropinirol
US7241456B2 (en) * 2002-10-25 2007-07-10 Australian Importers Ltd. Formulations for topical delivery of bioactive substances and methods for their use
US20070196453A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more non-volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196457A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Two or more volatile solvent-containing compositions and methods for dermal delivery of drugs
US20070196452A1 (en) * 2004-06-07 2007-08-23 Jie Zhang Flux-enabling compositions and methods for dermal delivery of drugs
US8741332B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for dermally treating neuropathic pain
US8741333B2 (en) * 2004-06-07 2014-06-03 Nuvo Research Inc. Compositions and methods for treating dermatitis or psoriasis
US8907153B2 (en) * 2004-06-07 2014-12-09 Nuvo Research Inc. Adhesive peel-forming formulations for dermal delivery of drugs and methods of using the same
US20070280972A1 (en) * 2006-04-25 2007-12-06 Zars, Inc. Adhesive solid gel-forming formulations for dermal drug delivery
DE102006048130A1 (de) * 2006-10-06 2008-04-10 Axxonis Pharma Ag Transdermales therapeutisches System mit zweiphasigem Freisetzungsprofil
US20090239894A1 (en) * 2008-03-20 2009-09-24 Bjorn Schurad Stabilized aqueous solutions of ergoline compounds

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3333240A1 (de) * 1983-09-12 1985-03-28 Schering AG, 1000 Berlin und 4709 Bergkamen Mittel zur transdermalen applikation von arzneimittelwirkstoffen
JPH0667835B2 (ja) * 1984-03-01 1994-08-31 サンド・アクチエンゲゼルシヤフト 医薬組成物
US4883669A (en) * 1985-02-25 1989-11-28 Rutgers, The State University Of New Jersey Transdermal absorption dosage unit for estradiol and other estrogenic steroids and process for administration
EP0208417A3 (en) * 1985-06-12 1989-09-06 SPOFA Spojené Podniky Pro Zdravotnickou Vyrobu Use of 1-(8-alpha-ergolinyl)-3,3-diethyl urea derivatives in the treatment of endometritis
US4835159A (en) * 1987-05-11 1989-05-30 Eli Lilly And Company Ergoline esters useful as serotonin antagonists
US4782063A (en) * 1987-05-11 1988-11-01 Eli Lilly And Company Ergoline esters useful as serotonin antagonists
US5229129A (en) * 1989-07-12 1993-07-20 Cygnus Therapeutic Systems Transdermal administration of lisuride
US5252335A (en) * 1989-07-12 1993-10-12 Cygnus Therapeutic Systems Transdermal administration of lisuride

Also Published As

Publication number Publication date
EP0538433B1 (de) 2004-04-21
JPH06500126A (ja) 1994-01-06
EP1027889B8 (de) 2006-07-05
IE921586A1 (en) 1992-11-18
PT100492A (pt) 1993-10-29
DE4116912A1 (de) 1992-11-26
AU1637792A (en) 1992-11-19
CA2068970A1 (en) 1993-11-20
US5399355A (en) 1995-03-21
NO930148L (no) 1993-01-15
EP1027889A2 (de) 2000-08-16
EP1027889B1 (de) 2005-12-07
HUT64227A (en) 1993-12-28
DE59210003D1 (de) 2006-01-12
NO930148D0 (no) 1993-01-15
HU9300125D0 (en) 1993-04-28
WO1992020339A1 (de) 1992-11-26
EP0538433A1 (de) 1993-04-28
JP3725153B2 (ja) 2005-12-07
ATE311862T1 (de) 2005-12-15
ATE264679T1 (de) 2004-05-15
ES2251936T3 (es) 2006-05-16
DE59209996D1 (de) 2004-05-27
ES2219639T3 (es) 2004-12-01
CA2068970C (en) 2005-09-27
EP1027889A3 (de) 2001-01-24
PT100492B (pt) 1999-06-30

Similar Documents

Publication Publication Date Title
DK1027889T3 (da) Middel til transdermal applikation indeholdende ergolinderivater
FI954616A (fi) Heterosyklisiä johdannaisia verihiutaleiden kasaantumisen inhibiittoreina
EP0359499A3 (en) Fluoro substituted benzocycloheptapyridine compounds, compositions and methods of use as antihistaminic compounds
DK0511541T3 (da)
GR3004139T3 (da)
AR241082A2 (es) Nuevos derivados de pirazol utiles como agentes herbicidas, las composiciones herbicidas que los contienen y los procedimientos para producir estos derivados de pirazol".
DK0630366T3 (da) Substituerede heterocycliske derivater, der er nyttige som blodpladeaggregeringsinhibitorer
FI900152A (fi) Med lyotropiska vaetskekristaller fungerande utdelningsanordning.
KR880701452A (ko) Ac 전류에 의해, 에너지화 되어 두 부분의 계합을 일으켜서 전자석을 제어하는 장치 및 그 방법
DE69416191T2 (de) Spiropyran-Derivate mit photochromischen Eigenschaften
FI893163A0 (fi) Menetelmä 19-hydroksylaasi-inhibiittoreina käyttökelpoisten 19-substituoitujen progesteronijohdannaisten valmistamiseksi
DE3873562T2 (de) Beta-alkylmelatonine.
DK275684A (da) Fremgangsmaade til debromering af 6,6-dibrom- eller 6-monobrom-penicillansyre eller derivater deraf
DK0462837T3 (da) Fremstilling af indol-derivater
ATE131160T1 (de) Flüssig-kristall-zusammensetzung und deren anwendung in einer flüssigkristall-vorrichtung.
DE3367103D1 (en) Sorbinil by optical resolution with aminopinane derivatives
FI893162A0 (fi) Som 19-hydroxylasinhibitorer anvaendbara 19-fluor- eller cyano-21-hydroxiprogesteronderivat.
ATE31190T1 (de) Verfahren zur herstellung von 2-azetidinonen.